Studies have demonstrated that blocking the interaction between YAP1 and TEAD or targeting TEAD auto-palmitoylation can effectively inhibit tumor formation and suppress tumor growth in the YAP1 fusion/NF2 mutant meningioma and schwannoma [15,20,21]. The gene discussed is NF2; the disease is neoplasm.